title: Will emerging pharmacotherapies improve the management of polycystic ovarian syndrome?
authors.affiliation: a Unit of Obstetrics and Gynaecology, Department of Experimental and Clinical Medicine , 'Magna Graecia' University , Catanzaro , Italy.
authors.forename: Morena Luigia
authors.initials: ML
authors.lastname: Rocca
authors.affiliation: a Unit of Obstetrics and Gynaecology, Department of Experimental and Clinical Medicine , 'Magna Graecia' University , Catanzaro , Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: Venturella
authors.affiliation: a Unit of Obstetrics and Gynaecology, Department of Experimental and Clinical Medicine , 'Magna Graecia' University , Catanzaro , Italy.
authors.forename: Rita
authors.initials: R
authors.lastname: Mocciaro
authors.affiliation: a Unit of Obstetrics and Gynaecology, Department of Experimental and Clinical Medicine , 'Magna Graecia' University , Catanzaro , Italy.
authors.forename: Fulvio
authors.initials: F
authors.lastname: Zullo
authors.affiliation: a Unit of Obstetrics and Gynaecology, Department of Experimental and Clinical Medicine , 'Magna Graecia' University , Catanzaro , Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Morelli
mesh_terms: D000293:Adolescent; D000328:Adult; D015195:Drug Design; D005260:Female; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D055815:Young Adult